UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT PURSUANT TO SECTION
13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): October 11, 2006
FIVE STAR QUALITY CARE, INC.
(Exact Name of Registrant as Specified in Its Charter)
Maryland
(State or other jurisdiction
of incorporation)
Commission File No. 1-16817 | 04-3516029 (IRS Employer Identification No.) |
|
400 Centre Street, Newton, Massachusetts 02458 (Address of Principal Executive Offices) (Zip Code) |
Registrant's telephone number, including area code: (617) 796-8387
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
Item 8.01. Other Events
On October 11, 2006, Five Star Quality Care, Inc. (the "Company" or "Five Star") announced that it intends to offer $80,000,000 aggregate principal amount of Convertible Senior Notes due 2026 to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended. A press release announcing the proposed offering is attached to this Current Report on Form 8-K as Exhibit 99.1.
WARNING CONCERNING FORWARD LOOKING STATEMENTS
THIS REPORT CONTAINS FORWARD LOOKING STATEMENTS WITHIN THE MEANING OF THE PRIVATE SECURITIES LITIGATION REFORM ACT OF 1995 AND FEDERAL SECURITIES LAWS, INCLUDING WITH RESPECT TO THE COMPANY'S
ISSUANCE OF THE NOTES AND ITS INTENDED USE OF THE PROCEEDS. THESE FORWARD LOOKING STATEMENTS ARE BASED UPON THE COMPANY'S PRESENT EXPECTATIONS, BUT THESE STATEMENTS AND THE IMPLICATIONS OF THESE STATEMENTS ARE NOT GUARANTEED.
Summary historical, pro forma and selected financial data of the Company; consolidating subsidiary financial information.
Summary historical and pro forma financial data
The following summary financial data related to our continuing operations has been derived from our historical financial statements for the six months ended June 30, 2006, and shows, for the period or date presented, our summary historical and our pro forma income statement and balance sheet data, giving effect to (1) our April 2006 equity offering; (2) the reduction in our management fees payable in respect of 10 SLS management agreements that we terminated in June 2006; and (3) this offering (assuming the initial purchasers over-allotment option is not exercised and not giving effect to conversion of the notes), as if these events had been completed as of the beginning of the period presented. The following data should be read in conjunction with, and is qualified in its entirety by reference to, our historical financial statements incorporated by reference from our Annual Report on Form 10-K for the year ended December 31, 2005 and our Quarterly Reports on Form 10-Q for the quarters ended March 31, 2006 and June 30, 2006 and "Management's Discussion and Analysis of Financial Condition and Results of Operations" contained therein, the information contained in this offering memorandum under "Risk Factors" and our unaudited pro forma financial statements contained in this offering memorandum. Our six month historical financial information contains normal recurring adjustments and is not necessarily indicative of results to be expected in a full year. Comparability of financial results from period to period is affected by acquisitions, closures and our termination of SLS management agreements. Pro forma financial information may not be reflective of what our financial results or financial position would have been had the April 2006 equity offering, the reduction in our management fees payable in respect of 10 SLS management agreements that we terminated in June 2006 and this offering been completed as of the dates indicated in our pro forma financial statements. Our pro forma financial information does not give pro forma effect to certain transactions, including, without limitation, the eight senior living communities we began to operate in
2
September and October 2006 and the two rehabilitation hospitals we began to operate in October 2006. You should not place undue reliance on our pro forma financial information.
|
For the six months ended June 30, 2006 |
|||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Historical |
Adjusted for April 2006 equity offering |
Adjusted for April 2006 equity offering and 2006 Sunrise terminations |
Adjusted for April 2006 equity offering, 2006 Sunrise terminations and convertible senior notes offering |
||||||||||
|
(amounts in thousands, except per share data) |
|||||||||||||
Statement of Income Data | ||||||||||||||
REVENUES: |
||||||||||||||
Net revenues from residents | $ | 365,398 | $ | 365,398 | $ | 365,398 | $ | 365,398 | ||||||
Pharmacy revenue | 24,410 | 24,410 | 24,410 | 24,410 | ||||||||||
Total revenues | 389,808 | 389,808 | 389,808 | 389,808 | ||||||||||
OPERATING EXPENSES: |
||||||||||||||
Community level operating expenses | 281,381 | 281,381 | 281,381 | 281,381 | ||||||||||
Termination payment to SLS | 89,833 | 89,833 | 89,833 | 89,833 | ||||||||||
Pharmacy expenses | 23,189 | 23,189 | 23,189 | 23,189 | ||||||||||
Management fee to SLS | 6,392 | 6,392 | 3,059 | 3,059 | ||||||||||
Rent expense | 52,563 | 52,563 | 52,563 | 52,563 | ||||||||||
General and administrative | 14,635 | 14,635 | 14,635 | 14,635 | ||||||||||
Depreciation and amortization | 4,561 | 4,561 | 4,561 | 4,561 | ||||||||||
Total operating expenses | 472,554 | 472,554 | 469,221 | 469,221 | ||||||||||
Operating loss | (82,746 | ) | (82,746 | ) | (79,413 | ) | (79,413 | ) | ||||||
Interest and other income | 1,140 | 1,140 | 1,140 | 1,140 | ||||||||||
Interest expense | (1,633 | ) | (1,633 | ) | (1,633 | ) | (3,294 | )(1) | ||||||
Loss from continuing operations before income taxes | (83,239 | ) | (83,239 | ) | (79,906 | ) | (81,567 | ) | ||||||
Provision for income taxes | | | | | ||||||||||
Loss from continuing operations | $ | (83,239 | ) | $ | (83,239 | ) | $ | (79,906 | ) | $ | (81,567 | ) | ||
Weighted Average Shares Outstanding: | ||||||||||||||
Basic | 25,551 | 31,581 | 31,581 | 31,581 | ||||||||||
Fully Diluted | 25,551 | 31,581 | 31,581 | 31,581 | ||||||||||
Basic and diluted income per share from continuing operations: |
||||||||||||||
Basic | $ | (3.26 | ) | $ | (2.64 | ) | $ | (2.53 | ) | $ | (2.58 | )(2) | ||
Fully Diluted | $ | (3.26 | ) | $ | (2.64 | ) | $ | (2.53 | ) | $ | (2.58 | )(2) | ||
EBITDA |
||||||||||||||
Loss from continuing operations | $ | (83,239 | ) | $ | (83,239 | ) | $ | (79,906 | ) | $ | (81,567 | ) | ||
Add: income taxes | | | | | ||||||||||
Add: depreciation and amortization | 4,561 | 4,561 | 4,561 | 4,561 | ||||||||||
Add: interest expense | 1,633 | 1,633 | 1,633 | 3,294 | ||||||||||
Less: interest and other income | (1,140 | ) | (1,140 | ) | (1,140 | ) | (1,140 | ) | ||||||
EBITDA(3) | $ | (78,185 | ) | $ | (78,185 | ) | $ | (74,852 | ) | $ | (74,852 | ) | ||
3
|
As of June 30, 2006 |
||||||
---|---|---|---|---|---|---|---|
|
Actual |
Adjusted for convertible senior notes offering |
|||||
|
(dollars in thousands) |
||||||
Balance Sheet Data | |||||||
Cash and cash equivalents | $ | 23,576 | $ | 101,126 | |||
Total current assets | 111,806 | 189,356 | |||||
Total assets | 252,334 | 332,334 | |||||
Total current liabilities | 83,889 | 83,889 | |||||
Total long term liabilities | 71,472 | 151,472 | |||||
Total shareholders' equity | $ | 96,973 | $ | 96,973 | |||
4
The following table presents selected financial data related to our continuing operations which has been derived from our historical financial statements for the years ended December 31, 2003, 2004 and 2005, and for the six months ended June 30, 2005 and 2006, all of which have been adjusted to remove the operations of two skilled nursing home communities in the state of Connecticut that we classified as discontinued operations in June 2006. The following information should be read in connection with, and is qualified in its entirety by reference to, our consolidated financial statements and the notes thereto incorporated by reference from our Annual Report on Form 10-K for the year ended December 31, 2005 and from our Quarterly Reports on Form 10-Q for the three months ended March 31, 2006 and the six months ended June 30, 2006. The six month information contains normal recurring adjustments and is not necessarily indicative of the results that may be expected in a full year. Additionally, comparability of financial results from period to period is affected by acquisitions, closures and our termination of SLS management agreements. Accordingly, you should not place undue reliance on our historical financial information.
|
Year ended December 31, |
Six months ended June 30, |
|||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
2003 |
2004 |
2005 |
2005 |
2006 |
||||||||||||
Revenues: | |||||||||||||||||
Net revenues from residents | $ | 543,610 | $ | 584,615 | $ | 700,891 | $ | 340,795 | $ | 365,398 | |||||||
Pharmacy revenue | 1,770 | 13,209 | 33,476 | 12,356 | 24,410 | ||||||||||||
Total revenues | 545,380 | 597,824 | 734,367 | 353,151 | 389,808 | ||||||||||||
Operating expenses: | |||||||||||||||||
Community level operating expenses | 434,530 | 455,755 | 537,062 | 260,061 | 281,381 | ||||||||||||
Pharmacy expenses | 1,666 | 12,093 | 32,167 | 11,451 | 23,189 | ||||||||||||
Management fee to SLS | 17,272 | 19,293 | 21,256 | 11,240 | 6,392 | ||||||||||||
Termination expense for certain SLS management agreements | | | 86,286 | | 89,833 | ||||||||||||
Rent expense | 76,962 | 82,453 | 98,890 | 48,460 | 52,563 | ||||||||||||
General and administrative | 15,892 | 18,473 | 26,559 | 12,702 | 14,635 | ||||||||||||
Depreciation and amortization | 3,201 | 3,371 | 7,113 | 3,384 | 4,561 | ||||||||||||
Impairment of assets | | | 2,333 | | | ||||||||||||
Total operating expenses | 549,523 | 591,438 | 811,666 | 347,298 | 472,554 | ||||||||||||
Operating (loss) income |
(4,143 |
) |
6,386 |
(77,299 |
) |
5,853 |
(82,746 |
) |
|||||||||
Interest and other income | 503 | 1,666 | 1,543 | 566 | 1,140 | ||||||||||||
Interest expense | (1,439 | ) | (1,172 | ) | (3,741 | ) | (1,860 | ) | (1,633 | ) | |||||||
(Loss) income from continuing operations before income taxes | (5,079 | ) | 6,880 | (79,497 | ) | 4,559 | (83,239 | ) | |||||||||
Provision for income taxes | | (120 | ) | | (73 | ) | | ||||||||||
(Loss) income from continuing operations | $ | (5,079 | ) | $ | 6,760 | $ | (79,497 | ) | $ | 4,486 | $ | (83,239 | ) | ||||
Weighted average shares outstanding | 8,482 | 8,716 | 14,879 | 12,219 | 25,551 | ||||||||||||
Basic and diluted (loss) income per share from: | |||||||||||||||||
Continuing operations | $ | (0.60 | ) | $ | 0.78 | $ | (5.34 | ) | $ | 0.37 | $ | (3.26 | ) | ||||
(Loss) income from continuing operations | $ | (5,079 | ) | $ | 6,760 | $ | (79,497 | ) | $ | 4,486 | $ | (83,239 | ) | ||||
Add: income taxes | | 120 | | 73 | | ||||||||||||
Add: depreciation and amortization | 3,201 | 3,371 | 7,113 | 3,384 | 4,561 | ||||||||||||
Add: interest expense | 1,439 | 1,172 | 3,741 | 1,860 | 1,633 | ||||||||||||
Less: interest and other income | (503 | ) | (1,666 | ) | (1,543 | ) | (566 | ) | (1,140 | ) | |||||||
EBITDA | $ | (942 | ) | $ | 9,757 | $ | (70,186 | ) | $ | 9,237 | $ | (78,185 | ) | ||||
5
CONSOLIDATING SUBSIDIARY FINANCIAL INFORMATION
Consolidating financial information related to the Company, its guarantor subsidiaries and non-guarantor subsidiaries as of June 30, 2006 and 2005 are reflected below.
UNAUDITED CONDENSED CONSOLIDATING STATEMENT OF OPERATIONS
For the six months ended June 30, 2006
|
Parent |
Guarantor subsidiaries |
Non-guarantor subsidiaries |
Eliminations |
FVE consolidated |
||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
REVENUES: | |||||||||||||||||
Net revenues from residents | $ | | $ | 163,152 | $ | 202,246 | $ | | $ | 365,398 | |||||||
Pharmacy revenue | | | 24,410 | | 24,410 | ||||||||||||
Total revenues | | 163,152 | 226,656 | | 389,808 | ||||||||||||
OPERATING EXPENSES: |
|||||||||||||||||
Wages and benefits | | 69,435 | 117,526 | | 186,961 | ||||||||||||
Other operating expenses | | 47,035 | 47,385 | | 94,420 | ||||||||||||
Termination payment to Sunrise Senior Living Services, Inc. ("SLS") | | 89,833 | | | 89,833 | ||||||||||||
Pharmacy expenses | | | 23,189 | | 23,189 | ||||||||||||
Management fee to SLS | | 6,392 | | | 6,392 | ||||||||||||
Rent expense | | 32,240 | 20,323 | | 52,563 | ||||||||||||
General and administrative | | 4,241 | 10,394 | | 14,635 | ||||||||||||
Depreciation and amortization | | 1,967 | 2,594 | | 4,561 | ||||||||||||
Total operating expenses | | 251,143 | 221,411 | | 472,554 | ||||||||||||
Operating (loss) income |
|
(87,991 |
) |
5,245 |
|
(82,746 |
) |
||||||||||
Interest and other income | | 65 | 1,075 | | 1,140 | ||||||||||||
Interest expense | | (3 | ) | (1,630 | ) | | (1,633 | ) | |||||||||
Equity in earnings of subsidiaries | (85,532 | ) | | | 85,532 | | |||||||||||
(Loss) income from continuing operations before income taxes | (85,532 | ) | (87,929 | ) | 4,690 | 85,532 | (83,239 | ) | |||||||||
Provision for income taxes | | | | | | ||||||||||||
(Loss) income from continuing operations |
(85,532 |
) |
(87,929 |
) |
4,690 |
85,532 |
(83,239 |
) |
|||||||||
Loss from discontinued operations |
|
(94 |
) |
(2,199 |
) |
|
(2,293 |
) |
|||||||||
Net (loss) income |
$ |
(85,532 |
) |
$ |
(88,023 |
) |
$ |
2,491 |
$ |
85,532 |
$ |
(85,532 |
) |
||||
6
UNAUDITED CONDENSED CONSOLIDATING STATEMENT OF OPERATIONS
For the six months ended June 30, 2005
|
Parent |
Guarantor subsidiaries |
Non-guarantor subsidiaries |
Eliminations |
FVE consolidated |
||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
REVENUES: | |||||||||||||||||
Net revenues from residents | $ | | $ | 156,638 | $ | 184,157 | $ | | $ | 340,795 | |||||||
Pharmacy revenue | | | 12,356 | | 12,356 | ||||||||||||
Total revenues | | 156,638 | 196,513 | | 353,151 | ||||||||||||
OPERATING EXPENSES: |
|||||||||||||||||
Wages and benefits | | 65,697 | 108,629 | | 174,326 | ||||||||||||
Other operating expenses | | 43,229 | 42,506 | | 85,735 | ||||||||||||
Termination payment to SLS | | | | | | ||||||||||||
Pharmacy expenses | | | 11,451 | | 11,451 | ||||||||||||
Management fee to SLS | | 11,148 | 92 | | 11,240 | ||||||||||||
Rent expense | | 32,201 | 16,259 | | 48,460 | ||||||||||||
General and administrative | | | 12,702 | | 12,702 | ||||||||||||
Depreciation and amortization | | 1,251 | 2,133 | | 3,384 | ||||||||||||
Total operating expenses | | 153,526 | 193,772 | | 347,298 | ||||||||||||
Operating income |
|
3,112 |
2,741 |
|
5,853 |
||||||||||||
Interest and other income | | 59 | 507 | | 566 | ||||||||||||
Interest expense | | | (1,860 | ) | | (1,860 | ) | ||||||||||
Equity in earnings of subsidiaries | 2,420 | | | (2,420 | ) | | |||||||||||
Income (loss) from continuing operations before income taxes | 2,420 | 3,171 | 1,388 | (2,420 | ) | 4,559 | |||||||||||
Provision for income taxes | | | (73 | ) | | (73 | ) | ||||||||||
Income (loss) from continuing operations |
2,420 |
3,171 |
1,315 |
(2,420 |
) |
4,486 |
|||||||||||
Loss from discontinued operations |
|
(71 |
) |
(1,995 |
) |
|
(2,066 |
) |
|||||||||
(Loss) net income |
$ |
2,420 |
$ |
3,100 |
$ |
(680 |
) |
$ |
(2,420 |
) |
$ |
2,420 |
|||||
7
UNAUDITED CONDENSED CONSOLIDATING BALANCE SHEET
As of June 30, 2006
|
Parent |
Guarantor subsidiaries |
Non-guarantor subsidiaries |
Eliminations |
FVE consolidated |
||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
ASSETS | |||||||||||||||
Current Assets |
|||||||||||||||
Cash and cash equivalents | $ | | $ | 2,499 | $ | 21,077 | $ | | $ | 23,576 | |||||
Accounts receivable, net | | 13,891 | 32,449 | | 46,340 | ||||||||||
Prepaid expenses and other current assets | | 2,479 | 39,411 | | 41,890 | ||||||||||
Total current assets | | 18,869 | 92,937 | | 111,806 | ||||||||||
Property and equipment, net |
|
19,820 |
82,230 |
|
102,050 |
||||||||||
Investment in subsidiary and long term recievable from (to) subsidiaries | 200 | | 200 | (400 | ) | | |||||||||
Restricted cash | | 3,673 | 10,024 | | 13,697 | ||||||||||
Intercompany | 227,808 | | | (227,808 | ) | | |||||||||
Mortgage notes receivable | | | 3,725 | | 3,725 | ||||||||||
Goodwill | | | 16,901 | | 16,901 | ||||||||||
Other long term assets | | 402 | 3,753 | | 4,155 | ||||||||||
Total assets | $ | 228,008 | $ | 42,764 | $ | 209,770 | $ | (228,208 | ) | $ | 252,334 | ||||
LIABILITIES AND SHAREHOLDERS' EQUITY |
|||||||||||||||
Current Liabilities |
|||||||||||||||
Accounts payable and other current liabilities | $ | | $ | 24,005 | $ | 59,258 | $ | | $ | 83,263 | |||||
Current mortgage notes payable | | | 626 | | 626 | ||||||||||
Total current liabilities | | 24,005 | 59,884 | | 83,889 | ||||||||||
Long term liabilities: |
|||||||||||||||
Mortgage notes payable | | | 44,423 | | 44,423 | ||||||||||
Notes payable to related parties | 200 | | | (200 | ) | | |||||||||
Other long term liabilities | | 7,128 | 19,921 | | 27,049 | ||||||||||
Total long term liabilities | 200 | 7,128 | 64,344 | (200 | ) | 71,472 | |||||||||
Total shareholders' equity |
227,808 |
11,631 |
85,542 |
(228,008 |
) |
96,973 |
|||||||||
Total liabilities and shareholders' equity |
$ |
228,008 |
$ |
42,764 |
$ |
209,770 |
$ |
(228,208 |
) |
$ |
252,334 |
||||
8
UNAUDITED CONDENSED CONSOLIDATING BALANCE SHEET
As of June 30, 2005
|
Parent |
Guarantor subsidiaries |
Non-guarantor subsidiaries |
Eliminations |
FVE consolidated |
||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
ASSETS | |||||||||||||||
Current Assets |
|||||||||||||||
Cash and cash equivalents | $ | | $ | 11,744 | $ | 6,960 | $ | | $ | 18,704 | |||||
Accounts receivable, net | | 12,937 | 26,315 | | 39,252 | ||||||||||
Prepaid expenses and other current assets | | 10,807 | 15,897 | | 26,704 | ||||||||||
Total current assets | | 35,488 | 49,172 | | 84,660 | ||||||||||
Property and equipment, net |
|
14,444 |
132,717 |
|
147,161 |
||||||||||
Investment in subsidiary and long term recievable from (to) subsidiaries | 200 | | 200 | (400 | ) | | |||||||||
Restricted cash | | 13,351 | 3,280 | | 16,631 | ||||||||||
Intercompany | 56,654 | | | (56,654 | ) | | |||||||||
Mortgage notes receivable | | | 6,036 | | 6,036 | ||||||||||
Goodwill | | | 14,842 | | 14,842 | ||||||||||
Other long term assets | | 402 | 1,502 | | 1,904 | ||||||||||
Total assets | $ | 56,854 | $ | 63,685 | $ | 207,749 | $ | (57,054 | ) | $ | 271,234 | ||||
LIABILITIES AND SHAREHOLDERS' EQUITY |
|||||||||||||||
Current Liabilities |
|||||||||||||||
Accounts payable and other current liabilities | $ | | $ | 27,396 | $ | 46,022 | $ | | $ | 73,418 | |||||
Current mortgage notes payable | | | 6,051 | | 6,051 | ||||||||||
Total current liabilities | | 27,396 | 52,073 | | 79,469 | ||||||||||
Long term liabilities: |
|||||||||||||||
Mortgage notes payable | | | 69,056 | | 69,056 | ||||||||||
Notes payable to related parties | 200 | | | (200 | ) | | |||||||||
Other long term liabilities | | 6,825 | 17,290 | | 24,115 | ||||||||||
Total long term liabilities | 200 | 6,825 | 86,346 | (200 | ) | 93,171 | |||||||||
Total shareholders' equity |
56,654 |
29,464 |
69,330 |
(56,854 |
) |
98,594 |
|||||||||
Total liabilities and shareholders' equity |
$ |
56,854 |
$ |
63,685 |
$ |
207,749 |
$ |
(57,054 |
) |
$ |
271,234 |
||||
9
UNAUDITED CONDENSED CONSOLIDATING CASH FLOW STATEMENT
For the six months ended June 30, 2006
|
Parent |
Guarantor subsidiaries |
Non-guarantor subsidiaries |
Eliminations |
FVE consolidated |
||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cash Flows from operating activities: | |||||||||||||||||
Net (loss) income | $ | (85,532 | ) | $ | (88,023 | ) | $ | 2,491 | $ | 85,532 | $ | (85,532 | ) | ||||
Undistributed equity in earnings of subsidiaries | 85,532 | | | (85,532 | ) | | |||||||||||
Adjustments to reconcile net income (loss) to cash provided by (used in) operating acitivities, net | | 86,027 | (92,220 | ) | | (6,193 | ) | ||||||||||
Net cash used in operating activities | | (1,996 | ) | (89,729 | ) | | (91,725 | ) | |||||||||
Cash Flows from investing activities: | |||||||||||||||||
Capital expenditures | | (8,323 | ) | (15,263 | ) | | (23,586 | ) | |||||||||
Proceeds from the sale of property and equipment | | 5,746 | 5,331 | | 11,077 | ||||||||||||
Other, net | | (4 | ) | (2,694 | ) | | (2,698 | ) | |||||||||
Net cash used in investing activities | | (2,581 | ) | (12,626 | ) | | (15,207 | ) | |||||||||
Cash Flows from financing activities: | |||||||||||||||||
Proceeds from issuance of common shares, net | | | 114,059 | | 114,059 | ||||||||||||
Change in borrowings, net | | | (280 | ) | | (280 | ) | ||||||||||
Other, net | | | | | | ||||||||||||
Net cash provided by financing activities | | | 113,779 | | 113,779 | ||||||||||||
Change in cash and cash equivalents | | (4,577 | ) | 11,424 | | 6,847 | |||||||||||
Cash and cash equivalents at beginning of period | | 7,076 | 9,653 | | 16,729 | ||||||||||||
Cash and cash equivalents at end of period | $ | | $ | 2,499 | $ | 21,077 | $ | | $ | 23,576 | |||||||
10
UNAUDITED CONDENSED CONSOLIDATING CASH FLOW STATEMENT
For the six months ended June 30, 2005
|
Parent |
Guarantor subsidiaries |
Non-guarantor subsidiaries |
Eliminations |
FVE consolidated |
||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cash Flows from operating activities: | |||||||||||||||||
Net income (loss) | $ | 2,420 | $ | 3,100 | $ | (680 | ) | $ | (2,420 | ) | $ | 2,420 | |||||
Undistributed equity in earnings of subsidiaries | (2,420 | ) | | | 2,420 | | |||||||||||
Adjustments to reconcile net income (loss) to cash provided by operating acitivities, net | | 7,691 | 8,662 | | 16,353 | ||||||||||||
Net cash provided by operating activities | | 10,791 | 7,982 | | 18,773 | ||||||||||||
Cash Flows from investing activities: | |||||||||||||||||
Capital expenditures | | (6,987 | ) | (79,827 | ) | | (86,814 | ) | |||||||||
Proceeds from the sale of property and equipment | | 3,988 | 25,574 | | 29,562 | ||||||||||||
Other, net | | (3,698 | ) | (2,587 | ) | | (6,285 | ) | |||||||||
Net cash used in investing activities | | (6,697 | ) | (56,840 | ) | | (63,537 | ) | |||||||||
Cash Flows from financing activities: | |||||||||||||||||
Proceeds from issuance of common shares, net | | | | | | ||||||||||||
Change in borrowings, net | | | 32,526 | | 32,526 | ||||||||||||
Other, net | | | | | | ||||||||||||
Net cash provided by financing activities | | | 32,526 | | 32,526 | ||||||||||||
Change in cash and cash equivalents | | 4,094 | (16,332 | ) | | (12,238 | ) | ||||||||||
Cash and cash equivalents at beginning of period | | 7,650 | 23,292 | | 30,942 | ||||||||||||
Cash and cash equivalents at end of period | $ | | $ | 11,744 | $ | 6,960 | $ | | $ | 18,704 | |||||||
11
Consolidating financial information related to the Company, its guarantor subsidiaries and non-guarantor subsidiaries as of December 31, 2005, 2004 and 2003 are reflected below.
UNAUDITED CONDENSED CONSOLIDATING STATEMENT OF OPERATIONS
For the year ended December 31, 2005
|
Parent |
Guarantor subsidiaries |
Non-guarantor subsidiaries |
Eliminations |
FVE consolidated |
||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
REVENUES: | |||||||||||||||||
Net revenues from residents | $ | | $ | 314,990 | $ | 385,901 | $ | | $ | 700,891 | |||||||
Pharmacy revenue | | | 33,476 | | 33,476 | ||||||||||||
Total revenues | | 314,990 | 419,377 | | 734,367 | ||||||||||||
OPERATING EXPENSES: |
|||||||||||||||||
Wages and benefits | | 131,779 | 224,588 | | 356,367 | ||||||||||||
Other operating expenses | | 90,368 | 90,327 | | 180,695 | ||||||||||||
Termination payment to SLS | | 86,286 | | | 86,286 | ||||||||||||
Pharmacy expenses | | | 32,167 | | 32,167 | ||||||||||||
Management fee to SLS | | 21,256 | | | 21,256 | ||||||||||||
Rent expense | | 64,556 | 34,334 | | 98,890 | ||||||||||||
General and administrative | | | 26,559 | | 26,559 | ||||||||||||
Depreciation and amortization | | 2,562 | 4,551 | | 7,113 | ||||||||||||
Impairment of assets | | | 2,333 | | 2,333 | ||||||||||||
Total operating expenses | | 396,807 | 414,859 | | 811,666 | ||||||||||||
Operating (loss) income |
|
(81,817 |
) |
4,518 |
|
(77,299 |
) |
||||||||||
Interest and other income | | 170 | 1,373 | | 1,543 | ||||||||||||
Interest expense | | | (3,741 | ) | | (3,741 | ) | ||||||||||
Equity in earnings of subsidiaries | (84,159 | ) | | | 84,159 | | |||||||||||
(Loss) income from continuing operations before income taxes | (84,159 | ) | (81,647 | ) | 2,150 | 84,159 | (79,497 | ) | |||||||||
Provision for income taxes | | | | | | ||||||||||||
(Loss) income from continuing operations | (84,159 | ) | (81,647 | ) | 2,150 | 84,159 | (79,497 | ) | |||||||||
Loss from discontinued operations |
|
(272 |
) |
(4,390 |
) |
|
(4,662 |
) |
|||||||||
Net (loss) income | $ | (84,159 | ) | $ | (81,919 | ) | $ | (2,240 | ) | $ | 84,159 | $ | (84,159 | ) | |||
12
UNAUDITED CONDENSED CONSOLIDATING STATEMENT OF OPERATIONS
For the year ended December 31, 2004
|
Parent |
Guarantor subsidiaries |
Non-guarantor subsidiaries |
Eliminations |
FVE consolidated |
||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
REVENUES: | |||||||||||||||||
Net revenues from residents | $ | | $ | 302,760 | $ | 281,855 | $ | | $ | 584,615 | |||||||
Pharmacy revenue | | | 13,209 | | 13,209 | ||||||||||||
Total revenues | | 302,760 | 295,064 | | 597,824 | ||||||||||||
OPERATING EXPENSES: |
|||||||||||||||||
Wages and benefits | | 126,868 | 175,414 | | 302,282 | ||||||||||||
Other operating expenses | | 88,287 | 65,186 | | 153,473 | ||||||||||||
Termination payment to SLS | | | | | | ||||||||||||
Pharmacy expenses | | | 12,093 | | 12,093 | ||||||||||||
Management fee to SLS | | 19,293 | | | 19,293 | ||||||||||||
Rent expense | | 64,023 | 18,430 | | 82,453 | ||||||||||||
General and administrative | | | 18,473 | | 18,473 | ||||||||||||
Depreciation and amortization | | 1,339 | 2,032 | | 3,371 | ||||||||||||
Total operating expenses | | 299,810 | 291,628 | | 591,438 | ||||||||||||
Operating income |
|
2,950 |
3,436 |
|
6,386 |
||||||||||||
Interest and other income | | 66 | 1,600 | | 1,666 | ||||||||||||
Interest expense | | | (1,172 | ) | | (1,172 | ) | ||||||||||
Equity in earnings of subsidiaries | 3,291 | | | (3,291 | ) | | |||||||||||
Income (loss) from continuing operations before income taxes | 3,291 | 3,016 | 3,864 | (3,291 | ) | 6,880 | |||||||||||
Provision for income taxes | | | (120 | ) | | (120 | ) | ||||||||||
Income (loss) from continuing operations | 3,291 | 3,016 | 3,744 | (3,291 | ) | 6,760 | |||||||||||
Loss from discontinued operations |
|
(692 |
) |
(2,777 |
) |
|
(3,469 |
) |
|||||||||
Net income (loss) | $ | 3,291 | $ | 2,324 | $ | 967 | $ | (3,291 | ) | $ | 3,291 | ||||||
13
UNAUDITED CONDENSED CONSOLIDATING STATEMENT OF OPERATIONS
For the year ended December 31, 2003
|
Parent |
Guarantor subsidiaries |
Non-guarantor subsidiaries |
Eliminations |
FVE consolidated |
||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
REVENUES: | |||||||||||||||||
Net revenues from residents | $ | | $ | 289,882 | $ | 253,728 | $ | | $ | 543,610 | |||||||
Pharmacy revenue | | | 1,770 | | 1,770 | ||||||||||||
Total revenues | | 289,882 | 255,498 | | 545,380 | ||||||||||||
OPERATING EXPENSES: |
|||||||||||||||||
Wages and benefits | | 125,605 | 166,029 | | 291,634 | ||||||||||||
Other operating expenses | | 85,587 | 57,309 | | 142,896 | ||||||||||||
Termination payment to SLS | | | | | | ||||||||||||
Pharmacy expenses | | | 1,666 | | 1,666 | ||||||||||||
Management fee to SLS | | 17,272 | | | 17,272 | ||||||||||||
Rent expense | | 63,728 | 13,234 | | 76,962 | ||||||||||||
General and administrative | | | 15,892 | | 15,892 | ||||||||||||
Depreciation and amortization | | 419 | 2,782 | | 3,201 | ||||||||||||
Total operating expenses | | 292,611 | 256,912 | | 549,523 | ||||||||||||
Operating loss |
|
(2,729 |
) |
(1,414 |
) |
|
(4,143 |
) |
|||||||||
Interest and other income | | 57 | 446 | | 503 | ||||||||||||
Interest expense | | | (1,439 | ) | | (1,439 | ) | ||||||||||
Equity in earnings of subsidiaries | (7,939 | ) | | | 7,939 | | |||||||||||
(Loss) income from continuing operations before income taxes | (7,939 | ) | (2,672 | ) | (2,407 | ) | 7,939 | (5,079 | ) | ||||||||
Provision for income taxes | | | | | | ||||||||||||
(Loss) income from continuing operations | (7,939 | ) | (2,672 | ) | (2,407 | ) | 7,939 | (5,079 | ) | ||||||||
Loss from discontinued operations |
|
(803 |
) |
(2,057 |
) |
|
(2,860 |
) |
|||||||||
Net (loss) income | $ | (7,939 | ) | $ | (3,475 | ) | $ | (4,464 | ) | $ | 7,939 | $ | (7,939 | ) | |||
14
UNAUDITED CONDENSED CONSOLIDATING BALANCE SHEET
As of December 31, 2005
|
Parent |
Guarantor subsidiaries |
Non-guarantor subsidiaries |
Eliminations |
FVE consolidated |
||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
ASSETS | |||||||||||||||
Current assets | |||||||||||||||
Cash and cash equivalents | $ | | $ | 7,076 | $ | 9,653 | $ | | $ | 16,729 | |||||
Accounts receivable, net | | 15,535 | 30,589 | | 46,124 | ||||||||||
Prepaid expenses and other current assets | | 6,143 | 25,884 | | 32,027 | ||||||||||
Total current assets | | 28,754 | 66,126 | | 94,880 | ||||||||||
Property and equipment, net |
|
19,200 |
77,543 |
|
96,743 |
||||||||||
Investment in subsidiary and long term recievable from (to) subsidiaries | 200 | | 200 | (400 | ) | | |||||||||
Restricted cash | | 3,798 | 9,159 | | 12,957 | ||||||||||
Intercompany | 113,749 | | | (113,749 | ) | | |||||||||
Mortgage notes receivable | | | 5,971 | | 5,971 | ||||||||||
Goodwill | | | 14,059 | | 14,059 | ||||||||||
Other long term assets | | 402 | 3,928 | | 4,330 | ||||||||||
Total assets | $ | 113,949 | $ | 52,154 | $ | 176,986 | $ | (114,149 | ) | $ | 228,940 | ||||
LIABILITIES AND SHAREHOLDERS' EQUITY | |||||||||||||||
Accounts payable and other current liabilities |
$ |
|
$ |
25,262 |
$ |
64,080 |
$ |
|
$ |
89,342 |
|||||
Current mortgage notes payable | | | 626 | | 626 | ||||||||||
Total current liabilities | | 25,262 | 64,706 | | 89,968 | ||||||||||
Long term liabilities: |
|||||||||||||||
Mortgage notes payable | | | 44,703 | | 44,703 | ||||||||||
Notes payable to related parties | 200 | | | (200 | ) | | |||||||||
Other long term liabilities | | 6,179 | 19,286 | | 25,465 | ||||||||||
Total long term liabilities | 200 | 6,179 | 63,989 | (200 | ) | 70,168 | |||||||||
Total shareholders' equity |
113,749 |
20,713 |
48,291 |
(113,949 |
) |
68,804 |
|||||||||
Total liabilities and shareholders' equity | $ | 113,949 | $ | 52,154 | $ | 176,986 | $ | (114,149 | ) | $ | 228,940 | ||||
15
UNAUDITED CONDENSED CONSOLIDATING BALANCE SHEET
As of December 31, 2004
|
Parent |
Guarantor subsidiaries |
Non-guarantor subsidiaries |
Eliminations |
FVE consolidated |
||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
ASSETS | |||||||||||||||
Current assets |
|||||||||||||||
Cash and cash equivalents | $ | | $ | 7,650 | $ | 23,292 | $ | | $ | 30,942 | |||||
Accounts receivable, net | | 11,676 | 25,066 | | 36,742 | ||||||||||
Prepaid expenses and other current assets | | 12,498 | 15,476 | | 27,974 | ||||||||||
Total current assets | | 31,824 | 63,834 | | 95,658 | ||||||||||
Property and equipment, net |
|
12,671 |
82,518 |
|
95,189 |
||||||||||
Investment in subsidiary and long term recievable from (to) subsidiaries | 200 | | 200 | (400 | ) | | |||||||||
Restricted cash | | 8,842 | 1,907 | | 10,749 | ||||||||||
Intercompany | 56,551 | | | (56,551 | ) | | |||||||||
Mortgage notes receivable | | | 6,099 | | 6,099 | ||||||||||
Goodwill | | | 11,548 | | 11,548 | ||||||||||
Other long term assets | | 402 | 3,340 | | 3,742 | ||||||||||
Total assets | $ | 56,751 | $ | 53,739 | $ | 169,446 | $ | (56,951 | ) | $ | 222,985 | ||||
LIABILITIES AND SHAREHOLDERS' EQUITY |
|||||||||||||||
Accounts payable and other current liabilities |
$ |
|
$ |
24,597 |
$ |
41,838 |
$ |
|
$ |
66,435 |
|||||
Current mortgage notes payable | | | 463 | | 463 | ||||||||||
Total current liabilities | | 24,597 | 42,301 | | 66,898 | ||||||||||
Long term liabilities: |
|||||||||||||||
Mortgage notes payable | | | 42,118 | | 42,118 | ||||||||||
Notes payable to related parties | 200 | | | (200 | ) | | |||||||||
Other long term liabilities | | 6,320 | 11,745 | | 18,065 | ||||||||||
Total long term liabilities | 200 | 6,320 | 53,863 | (200 | ) | 60,183 | |||||||||
Total shareholders' equity |
56,551 |
22,822 |
73,282 |
(56,751 |
) |
95,904 |
|||||||||
Total liabilities and shareholders' equity |
$ |
56,751 |
$ |
53,739 |
$ |
169,446 |
$ |
(56,951 |
) |
$ |
222,985 |
||||
16
UNAUDITED CONDENSED CONSOLIDATING CASH FLOW STATEMENT
For the year ended December 31, 2005
|
Parent |
Guarantor subsidiaries |
Non-guarantor subsidiaries |
Eliminations |
FVE consolidated |
||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cash Flows from operating activities: | |||||||||||||||||
Net (loss) income | $ | (84,159 | ) | $ | (81,919 | ) | $ | (2,240 | ) | $ | 84,159 | $ | (84,159 | ) | |||
Undistributed equity in earnings of subsidiaries | 84,159 | | | (84,159 | ) | | |||||||||||
Adjustments to reconcile net (loss) income to cash provided by (used in) operating acitivities, net | | 80,502 | (53,220 | ) | | 27,282 | |||||||||||
Net cash used in operating activities | | (1,417 | ) | (55,460 | ) | | (56,877 | ) | |||||||||
Cash Flows from investing activities: |
|||||||||||||||||
Capital expenditures | | (19,722 | ) | (90,632 | ) | | (110,354 | ) | |||||||||
Proceeds from the sale of property and equipment | | 7,769 | 88,379 | | 96,148 | ||||||||||||
Other, net | | 12,796 | (15,287 | ) | | (2,491 | ) | ||||||||||
Net cash provided by (used in) investing activities | | 843 | (17,540 | ) | | (16,697 | ) | ||||||||||
Cash Flows from financing activities: | |||||||||||||||||
Proceeds from issuance of common shares, net | | | 56,613 | | 56,613 | ||||||||||||
Change in borrowings, net | | | 2,748 | | 2,748 | ||||||||||||
Other, net | | | | | | ||||||||||||
Net cash provided by financing activities | | | 59,361 | | 59,361 | ||||||||||||
Change in cash and cash equivalents | | (574 | ) | (13,639 | ) | | (14,213 | ) | |||||||||
Cash and cash equivalents at beginning of period | | 7,650 | 23,292 | | 30,942 | ||||||||||||
Cash and cash equivalents at end of period | $ | | $ | 7,076 | $ | 9,653 | $ | | $ | 16,729 | |||||||
17
UNAUDITED CONDENSED CONSOLIDATING CASH FLOW STATEMENT
For the year ended December 31, 2004
|
Parent |
Subsidiaries |
Non-guarantor subsidiaries |
Eliminations |
FVE consolidated |
||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cash Flows from operating activities: | |||||||||||||||||
Net income (loss) | $ | 3,291 | $ | 2,324 | $ | 967 | $ | (3,291 | ) | $ | 3,291 | ||||||
Undistributed equity in earnings of subsidiaries | (3,291 | ) | | | 3,291 | | |||||||||||
Adjustments to reconcile net income (loss) to cash provided by (used in) operating acitivities, net | | 7,721 | (11,370 | ) | | (3,649 | ) | ||||||||||
Net cash provided by (used in) operating activities | | 10,045 | (10,403 | ) | | (358 | ) | ||||||||||
Cash Flows from investing activities: |
|||||||||||||||||
Capital expenditures | | (18,813 | ) | (123,648 | ) | | (142,461 | ) | |||||||||
Proceeds from the sale of property and equipment | | 5,746 | 126,393 | | 132,139 | ||||||||||||
Other, net | | (2,484 | ) | 4,262 | | 1,778 | |||||||||||
Net cash (used in) provided by investing activities | | (15,551 | ) | 7,007 | | (8,544 | ) | ||||||||||
Cash Flows from financing activities: |
|||||||||||||||||
Proceeds from issuance of common shares, net | | | 27,685 | | 27,685 | ||||||||||||
Change in borrowings, net | | | (5,452 | ) | | (5,452 | ) | ||||||||||
Other, net | | | | | | ||||||||||||
Net cash provided by financing activities | | | 22,233 | | 22,233 | ||||||||||||
Change in cash and cash equivalents | | (5,506 | ) | 18,837 | | 13,331 | |||||||||||
Cash and cash equivalents at beginning of period | | 13,156 | 4,455 | | 17,611 | ||||||||||||
Cash and cash equivalents at end of period | $ | | $ | 7,650 | $ | 23,292 | $ | | $ | 30,942 | |||||||
18
UNAUDITED CONDENSED CONSOLIDATING CASH FLOW STATEMENT
For the year ended December 31, 2003
|
Parent |
Guarantor subsidiaries |
Non-guarantor subsidiaries |
Eliminations |
FVE consolidated |
||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cash Flows from operating activities: | |||||||||||||||||
Net (loss) income | $ | (7,939 | ) | $ | (3,475 | ) | $ | (4,464 | ) | $ | 7,939 | $ | (7,939 | ) | |||
Undistributed equity in earnings of subsidiaries | 7,939 | | | (7,939 | ) | | |||||||||||
Adjustments to reconcile net income (loss) to cash provided by operating acitivities, net | | 26,226 | 625 | | 26,851 | ||||||||||||
Net cash provided by (used in) operating activities | | 22,731 | (3,839 | ) | | 18,912 | |||||||||||
Cash Flows from investing activities: |
|||||||||||||||||
Capital expenditures | | (4,365 | ) | (14,522 | ) | | (18,887 | ) | |||||||||
Proceeds from the sale of property and equipment | | 2,750 | 24,335 | | 27,085 | ||||||||||||
Other, net | | (10,633 | ) | (3,449 | ) | | (14,082 | ) | |||||||||
Net cash (used in) provided by investing activities | | (12,248 | ) | 6,364 | | (5,884 | ) | ||||||||||
Cash Flows from financing activities: |
|||||||||||||||||
Proceeds from issuance of common shares, net | | | | | | ||||||||||||
Change in borrowings, net | | | (5,687 | ) | | (5,687 | ) | ||||||||||
Other, net | | | | | | ||||||||||||
Net cash used in financing activities | | | (5,687 | ) | | (5,687 | ) | ||||||||||
Change in cash and cash equivalents | | 10,503 | (3,162 | ) | | 7,341 | |||||||||||
Cash and cash equivalents at beginning of period | | 2,654 | 7,616 | | 10,270 | ||||||||||||
Cash and cash equivalents at end of period | $ | | $ | 13,157 | $ | 4,454 | $ | | $ | 17,611 | |||||||
19
Five Star Quality Care, Inc.
UNAUDITED PRO FORMA FINANCIAL INFORMATION
UNAUDITED PRO FORMA CONSOLIDATED BALANCE SHEET
As of June 30, 2006
(dollars in
thousands)
|
Historical |
Adjustments for convertible senior notes offering |
Adjusted for convertible senior notes offering |
||||
---|---|---|---|---|---|---|---|
ASSETS | |||||||
Current assets |
|||||||
Cash and cash equivalents | $ | 23,576 | $77,550 | (A) | $101,126 | ||
Accounts receivable, net | 46,340 | | 46,340 | ||||
Prepaid expenses and other current assets | 41,890 | | 41,890 | ||||
Total current assets | 111,806 | 77,550 | 189,356 | ||||
Property and equipment, net |
102,050 |
|
102,050 |
||||
Restricted cash | 13,697 | | 13,697 | ||||
Mortgage notes receivable | 3,725 | | 3,725 | ||||
Goodwill | 16,901 | | 16,901 | ||||
Other long term assets | 4,155 | 2,450 | (B) | 6,605 | |||
Total assets | $ | 252,334 | $80,000 | $332,334 | |||
LIABILITIES AND SHAREHOLDERS' EQUITY |
|||||||
Total current liabilities |
$ |
83,889 |
$ |
$83,889 |
|||
Mortgage notes payable | 44,423 | | 44,423 | ||||
% Convertible Senior Notes due 2026 | | 80,000 | (C) | 80,000 | |||
Other long term liabilities | 27,049 | | 27,049 | ||||
Total liabilities | 155,361 | 80,000 | 235,361 | ||||
Total shareholders' equity |
96,973 |
|
96,973 |
||||
Total liabilities and shareholders' equity | $ | 252,334 | $80,000 | $332,334 | |||
20
Five Star Quality Care, Inc.
UNAUDITED PRO FORMA CONSOLIDATED INCOME STATEMENT
For the six months ended June 30, 2006
(dollars in thousands)
|
Historical |
Adjustments for April 2006 equity offering |
Adjusted for April 2006 equity offering |
Adjustments for 2006 Sunrise termination |
Adjusted for April 2006 equity offering and 2006 Sunrise termination |
Adjustments for convertible senior note offering |
Adjusted for April 2006 equity offering, 2006 Sunrise termination and convertible senior note offering |
||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
REVENUES: | |||||||||||||||||||||||
Net revenues from residents | $ | 365,398 | $ | | $ | 365,398 | $ | | $ | 365,398 | $ | | $ | 365,398 | |||||||||
Pharmacy revenue | 24,410 | | 24,410 | | 24,410 | | 24,410 | ||||||||||||||||
Total revenues | 389,808 | | 389,808 | | 389,808 | | 389,808 | ||||||||||||||||
OPERATING EXPENSES: |
|||||||||||||||||||||||
Property level operating expenses | 281,381 | | 281,381 | | 281,381 | | 281,381 | ||||||||||||||||
Termination payment to Sunrise Senior Living Services, Inc. | 89,833 | | 89,833 | | 89,833 | | 89,833 | ||||||||||||||||
Pharmacy expenses | 23,189 | | 23,189 | | 23,189 | | 23,189 | ||||||||||||||||
Management fee to Sunrise Senior Living Services, Inc. | 6,392 | | 6,392 | (3,333 | )(E) | 3,059 | | 3,059 | |||||||||||||||
Rent expense | 52,563 | | 52,563 | | 52,563 | | 52,563 | ||||||||||||||||
General and administrative | 14,635 | | 14,635 | | 14,635 | | 14,635 | ||||||||||||||||
Depreciation and amortization | 4,561 | | 4,561 | | 4,561 | | 4,561 | ||||||||||||||||
Total operating expenses | 472,554 | | 472,554 | (3,333 | ) | 469,221 | | 469,221 | |||||||||||||||
Operating loss |
(82,746 |
) |
|
(82,746 |
) |
3,333 |
(79,413 |
) |
|
(79,413 |
) |
||||||||||||
Interest and other income | 1,140 | | 1,140 | | 1,140 | | 1,140 | ||||||||||||||||
Interest expense | (1,633 | ) | | (1,633 | ) | | (1,633 | ) | (1,661 | )(F) | (3,294 | ) | |||||||||||
(Loss) income from continuing operations before income taxes | (83,239 | ) | | (83,239 | ) | 3,333 | (79,906 | ) | (1,661 | ) | (81,567 | ) | |||||||||||
Provision for income taxes | | | | | | | | ||||||||||||||||
(Loss) income from continuing operations |
$ |
(83,239 |
) |
$ |
|
$ |
(83,239 |
) |
$ |
3,333 |
$ |
(79,906 |
) |
$ |
(1,661 |
) |
$ |
(81,567 |
) |
||||
Weighted Average Shares Outstanding: | |||||||||||||||||||||||
Basic | 25,551 | 6,030 | (D) | 31,581 | | 31,581 | | 31,581 | |||||||||||||||
Fully Diluted | 25,551 | 6,030 | 31,581 | | 31,581 | | 31,581 | ||||||||||||||||
Basic and diluted loss per share from: |
|||||||||||||||||||||||
Basic | $ | (3.26 | ) | $ | (2.64 | ) | $ | (2.53 | ) | $ | (2.58 | ) | |||||||||||
Fully Diluted | $ | (3.26 | ) | $ | (2.64 | ) | $ | (2.53 | ) | $ | (2.58 | ) | |||||||||||
21
Five Star Quality Care, Inc.
NOTES TO UNAUDITED PRO FORMA CONSOLIDATED FINANCIAL STATEMENTS
(amounts in thousands, except share and per share amounts)
INTRODUCTION TO UNAUDITED PRO FORMA CONSOLIDATED FINANCIAL STATEMENTS
The unaudited pro forma consolidated balance sheet as of June 30, 2006, presents the consolidated financial position of Five Star as if this convertible senior notes offering had been completed as of June 30, 2006, as described in the notes thereto. The unaudited pro forma consolidated statement of operations for the six months ended June 30, 2006, presents the consolidated results of operations of Five Star as if (1) our April 2006 equity offering; (2) the reduction in our management fees payable in respect of 10 Sunrise Senior Living Services, Inc., or SLS, management agreements that we terminated in June 2006; and (3) this convertible senior notes offering (assuming the initial purchasers' over-allotment option is not exercised and not giving effect to the conversion of the notes), had been completed as of January 1, 2006, as described in the notes thereto.
These unaudited pro forma consolidated financial statements do not represent our consolidated financial condition or results of operations for any future date or period. Actual future results may be materially different from pro forma results. Differences could arise from many factors, including, but not limited to, those set forth under "Risk factors" and "Warning concerning forward looking statements." These unaudited pro forma consolidated financial statements should be read in conjunction with our historical financial statements incorporated by reference from our Annual Report on Form 10-K for the year ended December 31, 2005 and our Quarterly Reports on Form 10-Q for the quarters ended March 31, 2006 and June 30, 2006 and "Management's Discussion and Analysis of Financial Condition and Results of Operations" contained therein and the information contained in this offering memorandum under "Risk Factors." These unaudited pro forma consolidated financial statements do not give pro forma effect to certain transactions, including, without limitation, the eight senior living communities we began to operate in September and October 2006 and the two rehabilitation hospitals we began to operate in October 2006.
Pro forma consolidated balance sheet as of June 30, 2006 adjustments
Convertible senior notes issued | $ | 80,000 | |
Initial purchasers discount and commissions and other offering costs, estimated | 2,450 | ||
Net proceeds | $ | 77,550 | |
Pro forma consolidated statement of operations for the six months ended June 30, 2006 adjustments
22
Interest expense for six months on the $80,000 of convertible senior notes offered hereby at an assumed rate of 4.0% per annum | (1,600 | ) | ||
Amortization of deferred finance fees (see Note B) for six months. Deferred finance costs amortized over expected term of the convertible debt, or 20 years | (61 | ) | ||
Total adjustment | $ | (1,661 | ) | |
23
Item 9.01. Financial Statements and Exhibits.
10.1 | Seventh Amendment to Second Amended and Restated Lease Agreement, dated as of October 1, 2006, by and among Ellicott City Land I LLC, Ellicott City Land II LLC, HRES2 Properties Trust, SNH CHS Properties Trust, SPTIHS Properties Trust, SPT-Michigan Trust, SPTMNR Properties Trust, SNH/LTA Properties Trust and SNH/LTA Properties GA LLC, as Landlord, and Five Star Quality Care Trust, as Tenant. | |
10.2 |
Fourth Amendment to Credit and Security Agreement, dated as of October 11, 2006, by and among Five Star Quality Care, Inc., each of the Guarantors party thereto and Wachovia Bank, National Association. |
|
99.1 |
Press release of Five Star Quality Care, Inc., dated October 11, 2006. |
24
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
FIVE STAR QUALITY CARE, INC. |
||||
By: |
/s/ Evrett W. Benton |
|||
Name: | Evrett W. Benton | |||
Title: | President and Chief Executive Officer |
Date: October 11, 2006
25